Filing Details
- Accession Number:
- 0001209191-13-016170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-13 12:31:04
- Reporting Period:
- 2013-03-11
- Filing Date:
- 2013-03-13
- Accepted Time:
- 2013-03-13 12:31:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1396814 | Pacira Pharmaceuticals Inc. | PCRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1356950 | Paul James Scopa | C/O Mpm Asset Management 601 Gateway Blvd., Suite 350 South San Francisco CA 94080 | No | No | No | Yes | |
| 1358309 | Mpm Bioventures Iv Qp Lp | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | No | Yes | |
| 1358311 | Mpm Bioventures Iv Gp Llc | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | No | Yes | |
| 1358312 | Mpm Bioventures Iv Llc | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | No | Yes | |
| 1358313 | Mpm Asset Management Investors Bv4 Llc | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | No | Yes | |
| 1379218 | John Vort Vander | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | No | Yes | |
| 1412336 | Mpm Bioventures Iv Gmbh & Co. Beteiligungs Kg | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | No | Yes | |
| 1473930 | Todd Foley | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-03-11 | 500,000 | $27.86 | 2,790,479 | No | 4 | S | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See Footnote |
Footnotes
- The shares were sold as follows: 468,621 by MPM BioVentures IV-QP, L.P. ("BV IV QP"), 18,054 by MPM BioVentures IV GmbH & Co. Beteiligungs KG ("BV IV KG") and 13,325 by MPM Asset Management Investors BV4 LLC ("AM BV4"). MPM BioVentures IV GP LLC and MPM BioVentures IV LLC ("BV LLC") are the direct and indirect general partners of BV IV QP and BV IV KG and BV LLC is the manager of AM BV4. Vaughn M. Kailian, Ansbert Gadicke, Luke Evnin, James Paul Scopa, Todd Foley and John Vander Vort are the members of BV LLC.
- The shares are held as follows: 2,615,352 by BV IV QP, 100,758 by BV IV KG and 74,369 by AM BV4. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his, her or its respective pecuniary interest therein.
Billionaire Hedge Funds
